Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.9550 (-0.01%) ($42.9550 - $42.9550) on Mon. Apr. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 40 | Latest Price | $42.9550(-0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWO(49%) IWM(47%) IWC(43%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.43% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) IGOV(-3%) GLD(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $42.57(0.9%) | 10 Day Moving Average | $42.18(1.84%) | 20 Day Moving Average | $42.59(0.86%) | To recent high | -17.3% | To recent low | 8.5% | Market Cap | $5.871b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |